Patent ID: 9096819
Filing Date: 2015-08-04
Classification: A01N,A61K,A61L,C11D

Abstract:
1. An ophthalmic composition comprising: 0.01 wt. % to 2 wt. % of an amphoteric surfactant of general formula I wherein R 0.5 ppm to 2 ppm of α-[4-tris(2-hydroxyethyl)-ammonium chloride-2-butenyl]poly[1-dimethyl ammonium chloride-2-butenyl]-ω-tris(2-hydroxyethyl) ammonium chloride; 0.5 ppm to 2.0 ppm poly(hexamethylene biguanide); 0.01 wt. % to 0.05 wt. % ethylenediaminetetraacetic acid or a corresponding salt thereof; a borate buffer; and 0.002 wt. % to 0.03 wt. % of hyaluronic acid, wherein the ophthalmic composition satisfies the biocidal requirements of Stand-Alone Procedure for Disinfecting Products.